Open AccessEpidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses
Author(s) -
David Halpin,
Adrian Rabe,
Wei Jie Loke,
Sandra Grieve,
Patrick Daniele,
Sanghee Hwang,
A. Forsythe
Publication year - 2022
Publication title -
journal of asthma and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.162
H-Index - 30
ISSN - 1178-6965
DOI - 10.2147/jaa.s360985
Subject(s) - medicine , copd , asthma , meta analysis , odds ratio , systematic review , epidemiology , medline , confounding , intensive care medicine , mechanical ventilation , emergency medicine , intensive care unit , political science , law
There has been concern that asthma and chronic obstructive pulmonary disease [COPD] increase the risk of developing and exacerbating COVID-19. The effect of medications such as inhaled corticosteroids (ICS) and biologics on COVID-19 is unclear. This systematic literature review analyzed the published evidence on epidemiology and the burden of illness of asthma and COPD, and the use of baseline medicines among COVID-19 populations.